The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine

NeuroToxicology

Volumn 21, Issue 4, 2000, Pages 501-511

  Ogawa, T ^a   Mimura, Y ^a   Kato, H ^a   Ootsubo, S ^a   Murakoshi, M ^a  

^a Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Neuropathology; Neurotoxicity; Peripheral neuropathy; Rabbit model; Vincristine

Indexed keywords

VINCRISTINE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; DRUG EFFECT; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SENSORY NEUROPATHY;

ANIMAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEHAVIOR, ANIMAL; BRAIN; GANGLIA, SPINAL; MALE; NERVE FIBERS; NEUROTOXICITY SYNDROMES; RABBITS; SCIATIC NERVE; SPINAL CORD; TIME FACTORS; VINCRISTINE;

EID: 0033794186     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The fine structure of spheromembranous degeneration of skeletal muscle induced by vincristine
2. Peripheral neuropathy induced by 2,3,-dideoxycytidine. A rabbit model of 2,3,-dideoxycytidine neurotoxicity
3. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity
4. Glutamate ameliorates experimental vincristine neuropathy
5. The neuromyopathy of vincristine in the guinea pig. An electrophysiological and pathological study
6. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies
7. Clinical neurotoxic concerns on antineoplasic agents
8. Vincristine neuropathy. Clinical and electrophysiological observations
9. Distribution and excretion of 3H vincristine in the rat and the dog
10. The effect of vincristine on skeletal muscle in the rat. A correlative histochemical, ultrastructural and chemical study
11. Distribution and metabolism of vincristine in mice, rats, dogs and monkeys
12. Peripheral neuropathy induced by intravenous administration of vincristine sulfate in the rabbit
13. Vincristine (NSC-67574): A retrospective toxicologic evaluation in monkeys and dogs using weekly intravenous injections for 6 weeks
14. Vinca alkaloid neuropathy: Nerve biopsy studies in rats and in man
15. Vincristine treatment of advanced cancer: A cooperative study of 392 cases
16. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates
17. Blood-brain and blood-nerve barriers and their relationships to neurotoxicity
18. Studies on the morphological changes of skeletal muscle induced by vincristine, vinblastine and colchicine
19. Low doses of vincristine (NSC-67574) for malignant disease
20. Vincristine neurotoxicity. Pathophysiology and management
21. Taxol produces a predominantly sensory neuropathy
22. Image analysis of neuritic regeneratin by adult rat dorsal root ganglion neurons in culture: Quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-drived neurotophic factor or neurotrophin-3
23. Vincristine neuropathy: An electrophysiological and histological study
24. Neuropathy in lymphoblastic leukemia treated with vincristine
25. General toxicity and peripheral nerve alterations induced by chronic vincristine treatment in the rabbit
26. Paclitaxel-induced neuropathy
27. Effects of vincristine, maytansine, and cis-platinum on behavioral and electrophysiological indices of neurotoxicity in the rat
28. Vincristine neurotoxicity
29. Neurotoxicity of taxol
30. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients
31. Neurofibrillary degeneration induced by vincristine therapy
32. The effect of vincristine on nerve regeneration in the rat. An electrophysiological study
33. Spheromembranous degeneration of muscle induced by vincristine
34. Toxicology of vindesine (desacetyl vinblastineamide) in mice,rats and dogs
35. Animal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloids
36. Vincristine neurotoxicity in rodents